MARTIN COHEN

CIK 1181496 · Executive Chairman · last filed 2026-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$699.67M

Companies

7

Total Filings

89

Lifetime Open-Market Net

-$10.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CNS Director 9,021,542 $77.05 $695.11M -$12.37M 74 2026-04-03
LDP Co-Chairman 5,100 $20.61 $105.1K $126.0K 1 2012-09-24
RFI Co-Chairman 38,698 $11.33 $438.4K -$184.1K 4 2010-05-04
RQI Co-Chairman 101,685 $12.98 $1.32M $367.5K 2 2010-03-19
UTF Co-Chairman 25,489 $27.39 $698.2K $0 1 2010-03-16
RNP Co-Chairman 66,000 $20.51 $1.35M $319.7K 1 2008-12-24
FOF Co-Chairman 47,800 $13.46 $643.4K $1.38M 3 2007-05-18

Recent Filings · Page 4 of 9

89 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-10-04 CNS Mixed −19,675 $0 EDGAR
2021-07-02 CNS Grant (A) +304 $0 EDGAR
2021-04-05 CNS Grant (A) +375 $0 EDGAR
2021-01-05 CNS Grant (A) +341 $0 EDGAR
2020-10-02 CNS Grant (A) +447 $0 EDGAR
2020-07-02 CNS Mixed −24,634 $0 EDGAR
2020-04-03 CNS Grant (A) +581 $0 EDGAR
2020-02-04 CNS Tax (F) −1,066 -$80.3K EDGAR
2020-01-06 CNS Mixed −29,605 $0 EDGAR
2019-10-03 CNS Grant (A) +458 $0 EDGAR
Showing 3140 of 89
Page 4 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.